The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Abstract
'Jack of all trades, master of everything' is a fair label for transforming growth factor β1 (TGF-β) - a cytokine that controls our life at many levels. In the adult organism, TGF-β1 is critical for the development and maturation of immune cells, maintains immune tolerance and homeostasis, and regulates various aspects of immune responses. Following acute tissue damages, TGF-β1 becomes a master regulator of the healing process with impacts on about every cell type involved. Divergence from the tight control of TGF-β1 actions, for instance caused by chronic injury, severe trauma, or infection can tip the balance from regulated physiological to excessive pathological repair. This condition of fibrosis is characterized by accumulation and stiffening of collagenous scar tissue which impairs organ functions to the point of failure. Fibrosis and dysregulated immune responses are also a feature of cancer, in which tumor cells escape immune control partly by manipulating TGF-β1 regulation and where immune cells are excluded from the tumor by fibrotic matrix created during the stroma 'healing' response. Despite the obvious potential of TGF-β-signalling therapies, globally targeting TGF-β1 receptor, downstream pathways, or the active growth factor have proven to be extremely difficult if not impossible in systemic treatment regimes. However, TGF-β1 binding to cell receptors requires prior activation from latent complexes that are extracellularly presented on the surface of immune cells or within the extracellular matrix. These different locations have led to some divergence in the field which is often either seen from the perspective of an immunologists or a fibrosis/matrix researcher. Despite these human boundaries, there is considerable overlap between immune and tissue repair cells with respect to latent TGF-β1 presentation and activation. Moreover, the mechanisms and proteins employed by different cells and spatiotemporal control of latent TGF-β1 activation provide specificity that is amenable to drug development. This review aims at synthesizing the knowledge on TGF-β1 extracellular activation in the immune system and in fibrosis to further stimulate cross talk between the two research communities in solving the TGF-β conundrum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
Unsöld, C., Hyytiäinen, M. M., Bruckner‐Tuderman, L., & Keski‐Oja, J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.187 · Cited by 104
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
den Hollander, M. W., Bensch, F., Glaudemans, A. W. J. M., Munnink, T. H. O., Enting, R. H., den Dunnen, W. F. A., Heesters, M. A. A. M., Kruyt, F. A. E., Hooge, M. N. L., de Groot, J. C., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154401 · Cited by 104
Walton, K. L., Makanji, Y., Chen, J. B., Wilce, M. C. J., Chan, K. K. L., Robertson, D. M., & Harrison, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110288 · Cited by 102
TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs
Robertson, I. B., Jensen, S. A., & Handford, P. A. (2010) · Biochemical Journal · doi:10.1042/bj20101320 · Cited by 101
The role of TGF-beta signaling in dendritic cell tolerance
Esebanmen, G. E., & Langridge, W. H. R. (2017) · Immunologic Research · doi:10.1007/s12026-017-8944-9 · Cited by 101
Mechanistic insight into contextual TGF-β signaling
Zhang, Y. E. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.10.001 · Cited by 101
Edwards, J. P., Fujii, H., Zhou, A. X., Creemers, J. W. M., Unutmaz, D., & Shevach, E. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300199 · Cited by 98
Todorović, V., Frendewey, D. A., Gutstein, D. E., Chen, Y., Freyer, L., Finnegan, E., Liu, F., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2007) · Development · doi:10.1242/dev.008599 · Cited by 98
Oligodontia Is Caused by Mutation in LTBP3, the Gene Encoding Latent TGF-β Binding Protein 3
Noor, A., Windpassinger, C., Vitcu, I., Orlic-Milacic, M., Rafiq, M., Khalid, M., Malik, M. N., Ayub, M., Alman, B. A., & Vincent, J. B. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.007 · Cited by 97
Posttranslational Regulation of SmadsPreprint
Xu, P., Lin, X., & Feng, X. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022087 · Cited by 97
Latent TGF-β binding protein-2 is essential for the development of ciliary zonule microfibrils
Inoue, T., Ohbayashi, T., Fujikawa, Y., Yoshida, H., Akama, T. O., Noda, K., Horiguchi, M., Kameyama, K., Hata, Y., Takahashi, K. A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu283 · Cited by 96
Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
Alcaraz, L. B., Exposito, J.-Y., Chuvin, N., Pommier, R. M., Cluzel, C., Martel, S., Sentis, S., Bartholin, L., Lethias, C., & Valcourt, U. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201308031 · Cited by 94
Hirai, T., Zenke, Y., Yang, Y., Bartholin, L., Beura, L. K., Masopust, D., & Kaplan, D. H. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.002 · Cited by 92
Acharya, M., Mukhopadhyay, S., Païdassi, H., Jamil, T., Chow, C., Kissler, S., Stuart, L. M., Hynes, R. O., & Lacy‐Hulbert, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43796 · Cited by 91
Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease
Minagawa, S., Lou, J., Seed, R. I., Cormier, A., Wu, S., Cheng, Y., Murray, L., Tsui, P., Connor, J., Herbst, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008074 · Cited by 90
Ishigame, H., Zenewicz, L. A., Sanjabi, S., Licona-Limón, P., Nakayama, M., Leonard, W. J., & Flavell, R. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304498110 · Cited by 89
Amarnath, S., Li, D., Li, J., Wu, Y., & Chen, W. (2007) · Retrovirology · doi:10.1186/1742-4690-4-57 · Cited by 87
Stevenson, J. P., Kindler, H. L., Papasavvas, E., Sun, J., Jacobs-Small, M., Hull, J., Schwed, D., Ranganathan, A., Newick, K., Heitjan, D. F., et al. (2013) · OncoImmunology · doi:10.4161/onci.26218 · Cited by 85
It has to be the αv: myofibroblast integrins activate latent TGF-β1
Hinz, B. (2013) · Nature Medicine · doi:10.1038/nm.3421 · Cited by 80
Self-citationTGF‐β Control of Adaptive Immune Tolerance: A Break From Treg Cells
Liu, M., Li, S., & Li, M. O. (2018) · BioEssays · doi:10.1002/bies.201800063 · Cited by 80
Lung Alveolar Septation Defects in Ltbp-3-Null Mice
Colarossi, C., Chen, Y., Obata, H., Jurukovski, V., Fontana, L., Dabovic, B., & Rifkin, D. B. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62986-0 · Cited by 79
Sun, L., Jin, H., & Li, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8753 · Cited by 79
Targeting latency-associated peptide promotes antitumor immunity
Gabriely, G., da Cunha, A. P., Rezende, R. M., Kenyon, B. M., Madi, A., Vandeventer, T., Skillin, N. P., Rubino, S. J., Garo, L. P., Mazzola, M. A., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj1738 · Cited by 79
Dabovic, B., Chen, Y., Colarossi, C., Zambuto, L., Obata, H., & Rifkin, D. B. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750129 · Cited by 78
Effects of pirfenidone on the generation of reactive oxygen species in vitro.
Giri, S. N., Leonard, S. S., Shi, X., Margolin, S. B., & Vallyathan, V. (1999) · PubMed · Cited by 77
Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung
Koli, K. M., Wempe, F., Sterner‐Kock, A., Kantola, A. K., Komor, M., Hofmann, W., von Melchner, H., & Keski‐Oja, J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403067 · Cited by 74
Salem, M., Wallace, C. H., Velegraki, M., Li, A., Ansa-Addo, E. A., Metelli, A., Kwon, H., Riesenberg, B., Wu, B. X., Zhang, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2623 · Cited by 72
TGF-β Induces Surface LAP Expression on Murine CD4 T Cells Independent of Foxp3 Induction
Oida, T., & Weiner, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015523 · Cited by 71
Blakytny, R., & Brunner, G. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-05-0324 · Cited by 69
Ungefroren, H., Gieseler, F., Kaufmann, R., Settmacher, U., Lehnert, H., & Rauch, B. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061568 · Cited by 69
GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family
Lutz, M. B., Strobl, H., Schuler, G., & Romani, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01388 · Cited by 66
Vg1-Nodal heterodimers are the endogenous inducers of mesendoderm
Montague, T. G., & Schier, A. F. (2017) · eLife · doi:10.7554/elife.28183 · Cited by 66
Dedobbeleer, O., Stockis, J., van der Woning, B., Coulie, P. G., & Lucas, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601882 · Cited by 64
Role of GARP in the activation of latent TGF-β1
Stockis, J., Dedobbeleer, O., & Lucas, S. (2017) · Molecular BioSystems · doi:10.1039/c7mb00251c · Cited by 63
Zhou, Q., Haupt, S., Prots, I., Thümmler, K., Kremmer, E., Lipsky, P. E., Schulze‐Koops, H., & Skapenko, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202993 · Cited by 62
Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome
Zilberberg, L., Phoon, C. K. L., Robertson, I. B., Dabovic, B., Ramirez, F., & Rifkin, D. B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507652112 · Cited by 58
Cryo-EM structure of the αvβ8 integrin reveals a mechanism for stabilizing integrin extension
Cormier, A., Campbell, M. G., Ito, S., Wu, S., Lou, J., Marks, J. D., Baron, J. L., Nishimura, S. L., & Cheng, Y. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0093-x · Cited by 58
Carrillo-Gálvez, A. B., Cobo, M., Ocaña, S. C., Gutiérrez-Guerrero, A., Sánchez‐Gilabert, A., Bongarzone, P., García-Pérez, A., Muñoz, P., Benabdellah, K., Toscano, M. G., et al. (2014) · Stem Cells · doi:10.1002/stem.1821 · Cited by 57
Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex
Niu, J., Yue, W., Le-Le, Z., Liu, B., & Hu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.21549 · Cited by 56
Safer approaches to therapeutic modulation of TGF-β signaling for respiratory disease
Lachapelle, P., Li, M., Douglass, J. A., & Stewart, A. G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.010 · Cited by 56
Function of Latent TGFβ Binding Protein 4 and Fibulin 5 in Elastogenesis and Lung Development
Dabovic, B., Robertson, I. B., Zilberberg, L., Vassallo, M., Davis, E. C., & Rifkin, D. B. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24704 · Cited by 54
B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex
Wallace, C. H., Wu, B. X., Salem, M. A., Ansa-Addo, E. A., Metelli, A., Sun, S., Gilkeson, G. S., Shlomchik, M. J., Liu, B., & Li, Z. (2018) · JCI Insight · doi:10.1172/jci.insight.99863 · Cited by 54
Samid, M. A. A., Chaudhary, B., Khaled, Y. S., Ammori, B. J., & Elkord, E. (2016) · Oncotarget · doi:10.18632/oncotarget.7334 · Cited by 50
Latent TGF-β binding protein 2 and 4 have essential overlapping functions in microfibril development
Fujikawa, Y., Yoshida, H., Inoue, T., Ohbayashi, T., Noda, K., von Melchner, H., Iwasaka, T., Shiojima, I., Akama, T. O., & Nakamura, T. (2017) · Scientific Reports · doi:10.1038/srep43714 · Cited by 50
Warren, J., Im, M., Ballesteros, Á., Ha, C. T., Moore, T., Lambert, F., Lucas, S., Hinz, B., & Dveksler, G. S. (2018) · Molecular Human Reproduction · doi:10.1093/molehr/gay044 · Cited by 48
Self-citationLi, Y., Kim, B.-G., Qian, S., Letterio, J. J., Fung, J. J., Lu, L., & Lin, F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500139 · Cited by 45
Atypical interactions of integrin α V β 8 with pro-TGF-β1
Wang, J., Dong, X., Zhao, B., Li, J., Lu, C., & Springer, T. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705129114 · Cited by 44
GARP Is Regulated by miRNAs and Controls Latent TGF-β1 Production by Human Regulatory T Cells
Gauthy, E., Cuende, J., Stockis, J., Huygens, C., Lethé, B., Collet, J., Bommer, G. T., Coulie, P. G., & Lucas, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076186 · Cited by 41
Identification and characterization of latency-associated peptide-expressing γδ T cells
Rezende, R. M., da Cunha, A. P., Kuhn, C., Rubino, S. J., M’Hamdi, H., Gabriely, G., Vandeventer, T., Liu, S., Cialic, R., Pinheiro-Rosa, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9726 · Cited by 41
Profibrotic epithelial phenotype: a central role for MRTF and TAZ
Bialik, J. F., Ding, M., Speight, P., Dan, Q., Miranda, M. Z., Di Ciano-Oliveira, C., Kofler, M. M., Rotstein, O. D., Pedersen, S. F., Szászi, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40764-7 · Cited by 41
Worthington, J. J., Klementowicz, J. E., Rahman, S., Czajkowska, B. I., Smedley, C., Waldmann, H., Sparwasser, T. D., Grencis, R. K., & Travis, M. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003675 · Cited by 40
Does Breathing Amplify Fibrosis?
Hinz, B., & Suki, B. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0149ed · Cited by 39
Self-citationThe role of platelet and endothelial GARP in thrombosis and hemostasis
Vermeersch, E., Denorme, F., Maes, W., Meyer, S. F. D., Vanhoorelbeke, K., Edwards, J. P., Shevach, E. M., Unutmaz, D., Fujii, H., Deckmyn, H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173329 · Cited by 38
A key role of GARP in the immune suppressive tumor microenvironment
Hahn, S. A., Neuhoff, A., Landsberg, J., Schupp, J., Eberts, D., Leukel, P., Bros, M., Weilbaecher, M., Schuppan, D., Grabbe, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9598 · Cited by 36
LTBP-2 has multiple heparin/heparan sulfate binding sites
Parsi, M. K., Adams, J. R. J., Whitelock, J. M., & Gibson, M. A. (2010) · Matrix Biology · doi:10.1016/j.matbio.2010.03.005 · Cited by 35
New gene in the homologous human 11q13?q14 and mouse 7F chromosomal regions
Ollendorff, V., Szepetowski, P., Mattei, M.-G., Gaudray, P., & Birnbaum, D. (1992) · Mammalian Genome · doi:10.1007/bf00302877 · Cited by 35
Fibulin-4 exerts a dual role in LTBP-4L–mediated matrix assembly and function
Kumra, H., Nelea, V., Hakami, H., Pagliuzza, A., Djokic, J., Xu, J., Yanagisawa, H., & Reinhardt, D. P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901048116 · Cited by 35
Tolloid cleavage activates latent GDF8 by priming the pro‐complex for dissociation
Le, V. Q., Iacob, R. E., Tian, Y., McConaughy, W., Jackson, J., Su, Y., Zhao, B., Engen, J. R., Pirruccello, M., & Springer, T. A. (2018) · The EMBO Journal · doi:10.15252/embj.201797931 · Cited by 33
Garp as a therapeutic target for modulation of T regulatory cell function
Shevach, E. M. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1275568 · Cited by 31
Recent advances in understanding contextual TGFβ signaling
Ayyaz, A., Attisano, L., & Wrana, J. L. (2017) · F1000Research · doi:10.12688/f1000research.11295.1 · Cited by 31
Ma, W., Qin, Y., Chapuy, B., & Lu, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213482 · Cited by 30
TGF-β1 Regulates Antigen-Specific CD4+ T Cell Responses in the Periphery
Robinson, R., & Gorham, J. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.71 · Cited by 28
Horiguchi, M., Todorović, V., Hadjiolova, K., Weiskirchen, R., & Rifkin, D. B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.03.006 · Cited by 27
Wu, B. X., Li, A., Lei, L., Kaneko, S., Wallace, C. H., Li, X., & Li, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797613 · Cited by 26
Jin, H., Sun, L., Tang, L., Yu, W., & Li, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00138 · Cited by 25
Sciurba, J. C., Gieseck, R. L., Jiwrajka, N., White, S. D., Karmele, E. P., Redes, J., Vannella, K. M., Henderson, N. C., Wynn, T. A., & Hart, K. M. (2019) · The Journal of Pathology · doi:10.1002/path.5215 · Cited by 22
Enamel and dental anomalies in latent‐transforming growth factor beta‐binding protein 3 mutant mice
Morkmued, S., Hemmerlé, J., Mathieu, É., Laugel-Haushalter, V., Dabovic, B., Rifkin, D. B., Dollé, P., Niederreither, K., & Bloch‐Zupan, A. (2017) · European Journal Of Oral Sciences · doi:10.1111/eos.12328 · Cited by 21
Integrin alpha-v beta-8 in complex with the Fabs 8B8 and 68
Cormier, A., Campbell, M. G., Nishimura, S. L., & Cheng, Y. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6djp/pdb · Cited by 14
Targeting the myofibroblast to improve wound healing
Hinz, B. (2016) · Elsevier eBooks · doi:10.1016/b978-1-78242-455-0.00003-3 · Cited by 13
Self-citationTargeting immunosuppression by Tregs with monoclonal antibodies against GARP
Liénart, S., Stockis, J., Dedobbeleer, O., & Lucas, S. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1074379 · Cited by 7
Cited by
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Fibroblasts: Origins, definitions, and functions in health and disease
Plikus, M. V., Wang, X., Sinha, S., Forte, E., Thompson, S. M., Herzog, E. L., Driskell, R. R., Rosenthal, N., Biernaskie, J., & Horsley, V. (2021) · Cell · doi:10.1016/j.cell.2021.06.024 · Cited by 1,141
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
Younesi, F. S., Miller, A. E., Barker, T. H., Rossi, F. M. V., & Hinz, B. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00716-0 · Cited by 681
Self-citationTargeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413
“2a).3,31,36 Thrombospondin (TSP) is another activator of latent TGFβ that is present in the ECM; upon direct binding to LAP, TSP can induce the release of active TGFβ.37 In addition, the latent TGFβ binding protein (LTBP) can covalently bind to LAP, which facilitates the deposition of the SLC in the ECM and forms the…”
BackgroundInfluential
Metadata
- Authors
- Lodyga, M., & Hinz, B.
- Venue
- Seminars in Cell & Developmental Biology
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 101
- Pages
- 123-139
- ISSN
- 1084-9521 (ISSN-L)
- OpenAlex
- W2997221406
- Cited by
- 458
- References
- 270
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.